2026. Utilization of Corn Cob Hemicellulose in Swelling Tablet Formulations as a Novel Approach of Dietary Therapy. JURNAL FARMASIMED (JFM). 9, 1 (Oct. 2026), 1068–1074. DOI:https://doi.org/10.35451/jfm.v9i1.4075.